Teva Pharmaceutical Industries Ltd. (TEVA)
33.25
-0.94
(-2.75%)
USD |
NYSE |
Jun 08, 16:00
33.24
-0.01
(-0.03%)
After-Hours: 16:35
Teva Pharmaceutical Industries EPS Diluted (Quarterly) : 0.3121 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Viatris, Inc. | 0.1501 |
| Johnson & Johnson | 2.141 |
| Pfizer Inc. | 0.4688 |
| Novo Nordisk A/S | 1.709 |
| Novartis AG | 1.654 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 368.00M |
| Revenue (Quarterly) | 3.982B |
| Total Expenses (Quarterly) | 3.614B |
| Enterprise Value | 52.97B |
| Gross Profit Margin (Quarterly) | 49.64% |
| Profit Margin (Quarterly) | 9.24% |
| Earnings Yield | 4.05% |
| Operating Earnings Yield | 10.47% |
| Normalized Earnings Yield | 7.175 |